Found: 13
Select item for more details and to access through your institution.
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304552
- By:
- Publication type:
- Article
Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States.
- Published in:
- Journal of the International AIDS Society, 2024, v. 27, n. 3, p. 1, doi. 10.1002/jia2.26223
- By:
- Publication type:
- Article
Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
- Published in:
- AIDS & Behavior, 2022, v. 26, n. 5, p. 1333, doi. 10.1007/s10461-021-03490-8
- By:
- Publication type:
- Article
Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263664
- By:
- Publication type:
- Article
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States.
- Published in:
- Journal of the International AIDS Society, 2021, v. 24, n. 6, p. 1, doi. 10.1002/jia2.25747
- By:
- Publication type:
- Article
Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 7, p. 1136, doi. 10.1093/cid/ciy653
- By:
- Publication type:
- Article
Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 7, p. 1144, doi. 10.1093/cid/ciy654
- By:
- Publication type:
- Article
Prevalence and determinants of anal human papillomavirus infection in men who have sex with men and transgender women.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17).
- Published in:
- Medical Oncology, 2012, v. 29, n. 3, p. 2095, doi. 10.1007/s12032-012-0251-7
- By:
- Publication type:
- Article
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 5, p. 430, doi. 10.1111/j.1365-2141.2010.08387.x
- By:
- Publication type:
- Article
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 1, p. 48, doi. 10.1111/j.1365-2141.2009.07919.x
- By:
- Publication type:
- Article
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 2, p. 165, doi. 10.1111/j.1365-2141.2006.06276.x
- By:
- Publication type:
- Article
Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring.
- Published in:
- 1994
- By:
- Publication type:
- journal article